Beneficial Effect of Remote Glucose Monitoring and Computerized Insulin Dose Adjustment Algorithms Independent of Insulin Dose Increases in Sizeable Minorities of Patients [0.03%]
远程血糖监测和计算机化胰岛素剂量调整算法的有益效果独立于患者中相当一部分人的胰岛素剂量增加而存在
Mayer B Davidson,S Joshua Davidson,Petra Duran
Mayer B Davidson
This article describes a program through which interactions every 2-3 weeks between patients and primary care clinicians (PCCs), with recommendations based on analysis of remote glucose monitoring by computerized insulin dose adjustment alg...
Outcomes and Attributes Patients Value When Choosing Glucose-Lowering Medications: A Mixed-Methods Study [0.03%]
从患者选择降糖药物的角度出发：一种混合研究方法探讨患者重视的治疗结局和药物属性
Elizabeth H Golembiewski,Andrea E Garcia Bautista,Eric Polley et al.
Elizabeth H Golembiewski et al.
This mixed-methods study sought to identify pharmacotherapy preferences among 40 noninsulin-treated adults with type 2 diabetes receiving care at two U.S. health care systems. Participants ranked by relative importance various health outcom...
Dental Extractions Associated With Reduced Insulin Requirements in an Individual Using Concentrated Insulin: A Case Study [0.03%]
一例使用超浓胰岛素患者的拔牙与胰岛素需求量减少相关性分析：病例报告
Morgan P Stewart,Roxanne Powers,Kathryn Litten
Morgan P Stewart
A1C: Episode 2 [0.03%]
A1C：第2季
Nay Linn Aung
Nay Linn Aung
Quantifying and Characterizing the Presence of Insulin Overbasalization in a Family Medicine Practice [0.03%]
家庭医学实践中的胰岛素基础量过度校正的量化和特征描述
Autumn Stewart-Lynch,Rebekah Meyers,Dina Sidig et al.
Autumn Stewart-Lynch et al.
The American Diabetes Association advises clinicians of the potential for insulin overbasalization in the management of type 2 diabetes. Described as the titration of basal insulin beyond an appropriate dose, overbasalization increases risk...
Donislecel: First Cellular Therapy to Treat Patients With Brittle Type 1 Diabetes [0.03%]
DonaCel：治疗脆性1型糖尿病患者的首个细胞疗法
Ojashwi Giri,Jennifer D Goldman
Ojashwi Giri
Recent Advances in Diabetes Technology and Activities of the American Diabetes Association Diabetes Technology Interest Group [0.03%]
美国糖尿病协会糖尿病技术兴趣小组的近期活动及糖尿病技术的最新进展
Halis Kaan Akturk;American Diabetes Association Diabetes Technology Interest Group
Halis Kaan Akturk;American Diabetes Association Diabetes Technology Interest Group